JEFFREY C SELAN

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology EATONTOWN, NJ NPI 1134480205

General Payments — all program years on this page

$9,161.88

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 249
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,086.40 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,086.4020

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $3,589.53104
2019 $2,231.8685
2020 $329.246
2021 $679.0512
2022 $546.619
2023 $699.1913
2024 $1,086.4020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087169747 Novartis Pharmaceuticals Corporation $13.93 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092258003 Boston Scientific Corporation $95.48 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101418819 E.R. Squibb & Sons, L.L.C. $14.78 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101418877 E.R. Squibb & Sons, L.L.C. $15.80 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101418879 E.R. Squibb & Sons, L.L.C. $15.05 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104438937 AstraZeneca Pharmaceuticals LP $119.42 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117079383 Medtronic, Inc. $133.66 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117079385 Medtronic, Inc. $166.47 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117679547 Amgen Inc. $19.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131185895 PFIZER INC. $17.00 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142234916 ABIOMED $44.61 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142234962 ABIOMED $20.20 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142234994 ABIOMED $48.80 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142234996 ABIOMED $45.04 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142235034 ABIOMED $36.75 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142235040 ABIOMED $129.74 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152970135 ShockWave Medical, Inc $36.50 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152970163 ShockWave Medical, Inc $38.68 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152970339 ShockWave Medical, Inc $36.29 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152970355 ShockWave Medical, Inc $39.20 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.